Cargando…
Diagnosing hereditary cancer predisposition in men with prostate cancer
PURPOSE: We describe the pathogenic variant spectrum and identify predictors of positive results among men referred for clinical genetic testing for prostate cancer. METHODS: One thousand eight hundred twelve men with prostate cancer underwent clinical multigene panel testing between April 2012 and...
Autores principales: | Pritzlaff, Mary, Tian, Yuan, Reineke, Patrick, Stuenkel, A. J., Allen, Kyle, Gutierrez, Stephanie, Jackson, Michelle, Dolinsky, Jill S., LaDuca, Holly, Xu, Jianfeng, Black, Mary Helen, Helfand, Brian T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462744/ https://www.ncbi.nlm.nih.gov/pubmed/32439974 http://dx.doi.org/10.1038/s41436-020-0830-5 |
Ejemplares similares
-
Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients
por: LaDuca, Holly, et al.
Publicado: (2014) -
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
por: Pritzlaff, Mary, et al.
Publicado: (2016) -
Germline pathogenic variants in cancer risk genes among patients with thyroid cancer and suspected predisposition
por: Kamihara, Junne, et al.
Publicado: (2022) -
Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
por: Hu, Chunling, et al.
Publicado: (2018) -
Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer
por: Karam, Rachid, et al.
Publicado: (2019)